infectiousdiseaseadvisor.com8h
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
Hosted on MSN4d
Here’s A Trick That Could Help Save The Lives Of Diabetics Who Need Some In An Emergency. – ‘Draw up, there is still insulin in here.’
People who have diabetes need to have insulin on hand in order to keep their blood sugar at safe levels. Unfortunately, ...
Interesting Engineering on MSN9d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...
Medindia4y
Insulin Injections for Diabetes
Insulin Pen: A dispenser resembling a pen which contains insulin. Insulin Pumps: A pre-programmed pump worn around the abdomen that administers insulin on time.
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.